Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.

David Daeho KimMadison C SilverNatalia KunstJoshua T CohenDaniel A OllendorfPeter J Neumann

Published in: PharmacoEconomics (2021)

Researchers should justify and be transparent about their choice of perspective and costing approaches. The use of the impact inventory and reporting of disaggregate outcomes can reduce inconsistencies and confusion.

Keyphrases

adverse drug
type diabetes
emergency department
metabolic syndrome
decision making
weight loss
insulin resistance